Листа на меѓународни проекти со учество на Медицинскиот факултет Скопје

  1. TAIEX event 30751 – MK – TAIEX Workshop on Developing and unifying recommendations and guidelines for evaluation of complex DNA profiles of the forensic DNA experts in Balkan region according to the international guidelines, во соработка со ЕУ (2020).
  2. TAIEX event 30752 – MK – TAIEX Study Visit on Strengthening the knowledge of the DNA experts in the Republic of North Macedonia on the evaluation of complex DNA profiles according to the international guidelines, во соработка со ЕУ (2020).
  3.  “Effectiveness of combining feedback about lung age or exhaled CO levels with very brief advice (VBA) and support for smoking cessation in primary care compared to giving VBA and support alone”. Носител на проектот е  University of Birmingham – NIHR Global Health Research Group of Global COPD in Primary Care (2017-2020). Проф. д-р Катерина Ставриќ е главен истражувач од Медицинскиот факултет во Скопје. (завршен декември 2021)
  4. “Uniform noting for international application of the tumor-stroma ratio as easy diagnostic tool-UNITED”. Носител на проектот е Универзитетскиот Медицински Центар во Лајден, Холандија. Проф д-р Гордана Петрушевска е главен истражувач од Медицинскиот факултет во Скопје. (во тек)
  5. “Expert support for development, adaptation of a training courses for immunization health professionals and mangers in North Macedonia”. Носител на проект проф.д-р Катарина Ставриќ, во соработка со Светска здравствена организација, 07 July – 20 December 2021. (завршен декември 2021)
  6. “Expert support for adaptation and implementation of training package “Communicating with patients about COVID-19 vaccination” Носител на проект д-р Катерина Ковачевиќ во соработка со Светска здравствена организација. 20 August – 15 November 2021. (во тек)
  7. “Family Doctors – Partners in expanding access and choice to contraception and sexual and reproductive health services”. Центар за семејна медицина, Медицински Факултет, проф Катарина Ставриќ е партенр во проектот. Носител на проект ХЕРА (HERA – Health Education and Research Association), 01.04.2020 – 31.09.2022. (во тек)
  8. “Transferring simulation to medicine TRANSSIMED” Erasmus+ KA220-VET Cooperation partnerships in vocational education and training”. Носител на проект: Здравствен дом Љубљана Словенија, pартнери: Универзитет во Загреб,  Здравствен дом Загреб-Центар Хрватска и Центар за семејна медицина Медицински Факултет, Универзитет Св Кирил и Методиј Скопје.
  9. “European general practitioners attitudes towards person-centered care and factors that influence its implementation in everyday practice”. Носител на проект Goranka Petriček, Department of Family Medicine, “Andrija Stampar” School of Public Health, Schoolof Medicine, University of Zagreb, Health Centre Zagreb West, партнери 22 европски земји, Центар за семејна медицина Медицински Факултет, Универзитет Св Кирил и Методиј Скопје (период септември 2022-септември 2023)
  10. “Implementation of protocols for reliable application of antibody testing in management of COVID-19 crisis”. Serbia, s Official Development Assistanco (ODA) UNDP Serbia. Jan 2022 – March 2022. INSTITUT ZA PRIMENU NUKLEARNE ENERGIJE – INEP – dr Danica Ćujić, HEMIJSKI FAKULTET – Prof. dr Tanja Ćirković Veličković, INSTITUT ZA IMUNOBIOLOGIJA I HUMANA GENETIKA – Prof. dr Aleksandar Petličkovski.
  11. Project „Real-world effectiveness of COVID-19 vaccines in preventing symptomatic disease, hospitalization and death in the Macedonian population“ Chinese Center for Disease Control and Prevention, Jan 2022-Jan 2023. Principal investigators: Aleksandar Petlichkovski, Feng Zijian.

Меѓународни научноистражувачки проекти и клинички студии на Институтот за претклиничка и клиничка фармакологија со токсикологија:

  1. 1.”COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF VALSARTAN / INDAPAMIDE MR 160 mg / 1.5 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS”; (Sponsor Study Code: 21-702; CRO Study Code: LNI-268-21).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF VALSARTAN / INDAPAMIDE MR 160 mg / 1.5 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FED CONDITIONS”; (Sponsor Study Code: 21-714; CRO Study Code: LNI-269-21)
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER 4-WAY BIOAVAILABILITY STUDY OF EZETIMIBE/ATORVASTATIN 10 mg/ 80 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS”; (Sponsor Study Code: 21-711; CRO Study Code: ETA-230-21).
  1. Pharmacokinetic Characterization of benzydamine hydrochloride and cetylpyridinium chloride in Saliva after Single Dose of Septolete total lozenges (3 mg/1 mg) IN HEALTHY VOLUNTEERS ; (Sponsor Study Code: 21-719; CRO Study Code: PES-340-21).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER, 4-WAY BIOAVAILABILITY STUDY EDOXABAN 60 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS”; (Sponsor Study Code: 21-715; CRO Study Code: ODE-288-21).
  1. “COMPARATIVE, SINGLE-DOSE, 3-WAY CROSSOVER BIOAVAILABILITY STUDY OF EMPAGLIFLOZIN 25 MG TABLET FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FED CONDITION”; (Sponsor Study Code: 21-701; CRO Study Code: PME-207-21).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF CANDESARTAN / INDAPAMIDE 16 MG / 2.5 MG”; (Sponsor Study Code: 22-724; CRO Study Code: NNI-27-22).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF POMALIDOMIDE 4 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS”; (Sponsor Study Code: 22-725; CRO Study Code: MOP-28-22).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF CANDESARTAN / INDAPAMIDE 16 MG / 2.5 MG”; (Sponsor Study Code: 22-734; CRO Study Code: BAD-66-22).
  1. “PHARMACOKINETIC INTERACTION STUDY BETWEEN TELMISARTAN 80 MG AND INDAPAMIDE SR 1.5 MG FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITION”; (Sponsor Study Code: 21-699; CRO Study Code: LNI-168-22).
  1. “COMPARATIVE, RANDOMISED, MULTIPLE DOSE CROSSOVER BIOAVAILABILITY STUDY OF VALSARTAN/INDAPAMIDE MR 160 mg/1.5 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITION”; (Sponsor Study Code: 22-742; CRO Study Code: LNI-199-22)”.
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER 2-WAY PILOT BIOEQUVALENCE STUDY OF TWO PARACETAMOL 500 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITION””; (Sponsor Study Code: BEQPL-01-22; CRO Study Code: RAP-93-22).

Меѓународни проекти чиј носител е Медицинскиот факултет, финансирани од МОН и сѐ уште се во тек:

“Инференција и динамичко моделирање на ефективни мрежи од невролошки податоци: споредба со структурна и функционална поврзаност“, под раководство на вонр. проф д-р Томислав Станковски, македонско-кинески проект со Institute of Science and Technology for Brain-inspired Intelligence (ISTBI), Fudan University, Shanghai, China (2020-2021).